Research Article

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

Table 6

Proportion of specific tumor-TILs.

PatientTILs CD8+ IFN-γ+
R1 (%)R2 (%)

11.235.23
4NA3.2
5NA1.13
60.170.15
71.081.41

R1: first infusion of TILs; R2: second infusion of TILs; IFN-γ+: interferon-gamma; NA: data not available.